Oshima Go, Stack Melinda E, Wightman Sean C, Bryan Darren, Poli Elizabeth, Xue Lai, Skowron Kinga B, Uppal Abhineet, Pitroda Sean P, Huang Xiaona, Posner Mitchell C, Hellman Samuel, Weichselbaum Ralph R, Khodarev Nikolai N
Department of Surgery, The University of Chicago; Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago.
Department of Surgery, The University of Chicago.
J Vis Exp. 2016 Nov 30(117):54657. doi: 10.3791/54657.
Patients with a limited number of hepatic metastases and slow rates of progression can be successfully treated with local treatment approaches. However, little is known about the heterogeneity of liver metastases, and animal models capable of evaluating the development of individual metastatic colonies are needed. Here, we present an advanced model of hepatic metastases that provides the ability to quantitatively visualize the development of individual tumor clones in the liver and estimate their growth kinetics and colonization efficiency. We generated a panel of monoclonal derivatives of HCT116 human colorectal cancer cells stably labeled with luciferase and tdTomato and possessing different growth properties. With a splenic injection followed by a splenectomy, the majority of these clones are able to generate hepatic metastases, but with different frequencies of colonization and varying growth rates. Using the In Vivo Imaging System (IVIS), it is possible to visualize and quantify metastasis development with in vivo luminescent and ex vivo fluorescent imaging. In addition, Diffuse Luminescent Imaging Tomography (DLIT) provides a 3D distribution of liver metastases in vivo. Ex vivo fluorescent imaging of harvested livers provides quantitative measurements of individual hepatic metastatic colonies, allowing for the evaluation of the frequency of liver colonization and the growth kinetics of metastases. Since the model is similar to clinically observed liver metastases, it can serve as a modality for detecting genes associated with liver metastasis and for testing potential ablative or adjuvant treatments for liver metastatic disease.
肝转移数量有限且进展缓慢的患者可以通过局部治疗方法成功治疗。然而,关于肝转移的异质性知之甚少,因此需要能够评估单个转移瘤集落发展的动物模型。在此,我们提出了一种先进的肝转移模型,该模型能够定量可视化肝脏中单个肿瘤克隆的发展,并估计其生长动力学和定植效率。我们生成了一组稳定标记有荧光素酶和tdTomato且具有不同生长特性的HCT116人结肠癌细胞单克隆衍生物。通过脾内注射随后进行脾切除术,这些克隆中的大多数能够产生肝转移,但定植频率和生长速率各不相同。使用体内成像系统(IVIS),可以通过体内发光成像和体外荧光成像对转移发展进行可视化和量化。此外,漫射发光成像断层扫描(DLIT)可提供体内肝转移的三维分布。对收获肝脏的体外荧光成像可对单个肝转移瘤集落进行定量测量,从而评估肝脏定植频率和转移的生长动力学。由于该模型与临床观察到的肝转移相似,它可以作为一种检测与肝转移相关基因以及测试肝转移性疾病潜在消融或辅助治疗的方法。